Genfit S.A. (GNFTF)
USD 5.55
(0.0%)
USD 5.55
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 105.92 Million EUR | -18.22% |
| 2022 | 129.51 Million USD | -29.93% |
| 2021 | 184.84 Million USD | -29.59% |
| 2020 | 262.51 Million USD | 3.58% |
| 2019 | 253.44 Million USD | 6.32% |
| 2018 | 238.39 Million USD | 3.55% |
| 2017 | 230.22 Million USD | 832.12% |
| 2016 | 24.69 Million USD | 64.26% |
| 2015 | 15.03 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 104.34 Million USD | 0.0% |
| 2023 Q2 | 130.21 Million USD | 0.55% |
| 2023 Q3 | 111.97 Million USD | -14.01% |
| 2023 Q4 | 105.92 Million EUR | -5.41% |
| 2023 Q1 | 129.49 Million USD | -0.01% |
| 2023 FY | 105.92 Million EUR | -18.22% |
| 2022 Q2 | 134.02 Million USD | 0.0% |
| 2022 FY | 129.51 Million USD | -29.93% |
| 2022 Q3 | 118.58 Million USD | -11.52% |
| 2022 Q4 | 129.51 Million USD | 9.22% |
| 2021 Q2 | 119.94 Million USD | 0.0% |
| 2021 FY | 184.84 Million USD | -29.59% |
| 2021 Q4 | 184.84 Million USD | 0.0% |
| 2020 Q2 | 252.5 Million USD | 0.0% |
| 2020 FY | 262.51 Million USD | 3.58% |
| 2020 Q4 | 262.78 Million USD | 0.0% |
| 2019 Q4 | 253.44 Million USD | 0.0% |
| 2019 FY | 253.44 Million USD | 6.32% |
| 2019 Q2 | 259.26 Million USD | 0.0% |
| 2018 FY | 238.39 Million USD | 3.55% |
| 2017 FY | 230.22 Million USD | 832.12% |
| 2016 FY | 24.69 Million USD | 64.26% |
| 2015 FY | 15.03 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -98.707% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -1005.414% |
| SQZ Biotechnologies Company | 50.03 Million USD | -111.677% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -46.156% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -79.484% |
| Mesoblast Limited | 188.44 Million USD | 43.792% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -2650.178% |
| Genus plc | 485 Million USD | 78.161% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -1712.902% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -4109.348% |
| Marizyme, Inc. | 26.67 Million USD | -297.069% |
| ContraFect Corporation | 32.53 Million USD | -225.6% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -2687.395% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -5246.014% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -2667.261% |
| Intellipharmaceutics International Inc. | 12 Million USD | -782.031% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -799.297% |
| MultiCell Technologies, Inc. | 1617.67 USD | -6547650.777% |
| Accustem Sciences Inc. | 1.07 Million USD | -9714.416% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -36.819% |
| EV Biologics, Inc. | 2.11 Million USD | -4907.922% |
| Q BioMed Inc. | 8.13 Million USD | -1202.371% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -27.716% |
| Neon Bloom, Inc. | 1.22 Million USD | -8538.059% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -1958.303% |
| Biomind Labs Inc. | 1.49 Million USD | -6967.94% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | 56.603% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -475.551% |
| Skye Bioscience, Inc. | 14.07 Million USD | -652.695% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -5169.361% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -74442.384% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -1018.972% |
| IMV Inc. | 37.93 Million USD | -179.233% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -52566.62% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -1743.444% |
| GB Sciences, Inc. | 5.41 Million USD | -1855.143% |
| Alpha Cognition Inc. | 7.16 Million USD | -1378.358% |
| HST Global, Inc. | 593.59 Thousand USD | -17744.045% |
| CSL Limited | 18.62 Billion USD | 99.431% |
| Halberd Corporation | 728.71 Thousand USD | -14435.232% |
| Enzolytics Inc. | 365.26 Million USD | 71.002% |
| Resverlogix Corp. | 67.39 Million USD | -57.162% |
| Affymax, Inc. | 8.87 Million USD | -1094.014% |
| SYBLEU INC | 681.41 Thousand USD | -15444.317% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -12528.706% |
| argenx SE | 444.95 Million USD | 76.195% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -41.379% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -6079.755% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -789.861% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -2789.939% |
| AVAX Technologies, Inc. | 3.99 Million USD | -2552.172% |
| Zenith Capital Corp. | 27.56 Thousand USD | -384103.272% |
| Genscript Biotech Corporation | 1.32 Billion USD | 92.011% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -44282.663% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -2736.431% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -15457.537% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 10.782% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -1071.408% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -158158.752% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -7287.118% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -110.729% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -3806.159% |
| BioStem Technologies, Inc. | 15.9 Million USD | -565.974% |
| ONE Bio Corp. | 27.49 Million USD | -285.226% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -22693.464% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -386007.972% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -8311.816% |
| Agentix Corp. | 2.51 Million USD | -4119.027% |
| LadRx Corporation | 2.2 Million USD | -4713.436% |
| Cell Source, Inc. | 15.8 Million USD | -570.101% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -236880.938% |
| Regen BioPharma, Inc. | 5.45 Million USD | -1840.792% |
| Regen BioPharma, Inc. | 5.45 Million USD | -1840.792% |
| NovAccess Global Inc. | 7.86 Million USD | -1247.47% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -328.032% |
| Itoco Inc. | 1.65 Million USD | -6307.219% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -5062.937% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -1651.05% |
| Kadimastem Ltd | 3.5 Million USD | -2922.112% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -25025.484% |
| CytoDyn Inc. | 127.89 Million USD | 17.181% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -253305.584% |
| Mobile Lads Corp. | 1.31 Million USD | -7964.046% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -6662.165% |
| Qrons Inc. | 1.48 Million USD | -7014.938% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -858.97% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -12996.165% |
| Rebus Holdings, Inc. | 5.24 Million USD | -1920.622% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -1635.868% |
| International Stem Cell Corporation | 5.27 Million USD | -1907.22% |
| Bioxytran, Inc. | 3.24 Million USD | -3159.609% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -16825.452% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -2194.09% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -158.369% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -375.729% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -5129.667% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -1833.571% |
| Neutra Corp. | 973.52 Thousand USD | -10780.107% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -265.056% |
| PureTech Health plc | 125.58 Million USD | 15.657% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -2719.204% |
| IXICO plc | 1.9 Million USD | -5473.933% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -415.958% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -2.513% |
| CSL Limited | 18.62 Billion USD | 99.431% |
| Cellectis S.A. | 249.36 Million USD | 57.524% |